trial · primary record
OPN-6602
Relapsed Multiple Myeloma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2027-12 |
| Primary endpoint | Number and type of dose-limiting toxicities (DLTs) |
| Registry ID | NCT06433947 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:36.895Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06433947
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.